Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
about
Advances in mass spectrometry-based post-column bioaffinity profiling of mixturesChallenges of antibacterial discoveryAssay for Glycosaminoglycans by Tandem Mass Spectrometry and its Applications.Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.Establishment of glycosaminoglycan assays for mucopolysaccharidosesLabel-free screening assays: a strategy for finding better drug candidates.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Recent development in software and automation tools for high-throughput discovery bioanalysis.Mutant Alleles of lptD Increase the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics.Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core.FtsH-mediated coordination of lipopolysaccharide biosynthesis in Escherichia coli correlates with the growth rate and the alarmone (p)ppGpp.Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa.Control of lipopolysaccharide biosynthesis by FtsH-mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria.Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry.Avoiding misannotation of in-source fragmentation products as cellular metabolites in liquid chromatography-mass spectrometry-based metabolomics.
P2860
Q33755856-99614320-8430-4523-8CE8-0E91F7C86419Q33793074-E91947BF-6314-426D-A607-9D0B1B7BB267Q33945288-30EFCCC4-5668-4F0E-9EE4-017FE2BB9D91Q34257650-0916F255-0F97-4B69-956B-902C784BB46EQ34318230-4E5A23F3-6886-47D2-9360-2D149A652765Q37856304-66D6C6EB-E9BE-4B06-B88C-6BD394AD9324Q38011247-74BE3E56-8F5F-4750-8717-48DF7FCF3847Q38011790-9344805B-4840-4BE4-84AC-3B515FF5CAF6Q38367630-0DF86611-282B-468C-A0CA-F8462057A048Q39157474-F799B652-8189-447B-9E8B-F0BBD403E54AQ39799204-CACF2128-3331-4278-8162-4C61BD05E0A5Q40325143-D4EB83CA-0D37-4662-9828-5023A1F0467EQ41430702-C826706F-4BF1-4E9F-BC7A-9ACBD31EB7E6Q41483605-9EB51434-5CB0-417C-8525-045C8F3A3806Q42275406-0414D916-D64D-43C0-A6E2-684F23CF282E
P2860
Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Screening for antibacterial inhibitors of the UDP-3-O-
@nl
Screening for antibacterial in ...... ghput mass spectrometry assay.
@ast
Screening for antibacterial in ...... ghput mass spectrometry assay.
@en
type
label
Screening for antibacterial inhibitors of the UDP-3-O-
@nl
Screening for antibacterial in ...... ghput mass spectrometry assay.
@ast
Screening for antibacterial in ...... ghput mass spectrometry assay.
@en
prefLabel
Screening for antibacterial inhibitors of the UDP-3-O-
@nl
Screening for antibacterial in ...... ghput mass spectrometry assay.
@ast
Screening for antibacterial in ...... ghput mass spectrometry assay.
@en
P2093
P356
P1476
Screening for antibacterial in ...... ghput mass spectrometry assay.
@en
P2093
Asra Malikzay
Can C Ozbal
Charles A Lunn
Cynthia Kravec
Dayna Daubaras
Erik F Langsdorf
Lynn Miesel
Richard Hart
Todd Black
William A Lamarr
P356
10.1177/1087057109355319
P577
2009-12-17T00:00:00Z